Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.

• Dorssers, L.C.J.
• Grebenchtchikov, N.
• Brinkman, A.
• Look, M.P.
• Klijn, J.G.M.
• Geurts-Moespot, A.
• Span, P.N.
• Foekens, J.A.
• Sweep, C.G.
• , et al.

August 2004
Article

Related Files
Redirect to publisher's version (publisher's version.url.txt, 46 bytes)

• Adult
• Aged
• Aged, 80 and over
• Female
• Humans
• Research Support, Non-U.S. Gov't
• Middle Aged
• Predictive Value of Tests
• Enzyme-Linked Immunosorbent Assay
• Tamoxifen/*therapeutic use
• Crk-Associated Substrate Protein
• Retinoblastoma-Like Protein p130
• Proteins/*analysis
• Tumor Markers, Biological/*analysis
• Breast Neoplasms/*diagnosis/*drug therapy/pathology
• Estrogen Antagonists/*therapeutic use